Facebook Instagram X-twitter Linkedin

Follistatin (1mg)

Table of Contents

  • Quickstart Highlights

Follistatin (1mg) protocols center on this naturally occurring glycoprotein that binds and inhibits myostatin and activin A, both of which are key regulators that limit muscle growth. By blocking these pathways, follistatin may support significant increases in lean muscle mass, improved strength, and enhanced tissue growth signaling. This guide outlines a subcutaneous administration approach tailored to the 1 mg vial format.

  • Reconstitute: Add 1.0 mL bacteriostatic water → 1 mg/mL concentration
  • Typical dosing range: 50–200 mcg per day or spaced protocol dosing (subcutaneous)
  • Easy measuring: At 1 mg/mL, 1 unit = 0.01 mL = 10 mcg on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks
  • Protocol Overview

Concise summary of the subcutaneous regimen.

  • Goal: Support muscle growth by inhibiting myostatin and activin signaling
  • Schedule: Short-cycle or spaced dosing protocols due to strong biological activity
  • Dose Range: 50–200 mcg per day (or intermittent dosing depending on protocol design)
  • Dosing Protocol

Suggested approach for the 1 mg vial format.

  • Start: 50 mcg once daily or every other day to assess tolerance
  • Target: 100–200 mcg per day or split dosing protocols
  • Frequency: Daily or every other day, depending on the cycle structure
  • Vial Duration: One 1 mg vial typically lasts 5–20 days, depending on dose
  • Timing: Flexible; often used consistently at the same time each day or during training cycles
  • Mechanism of Action

Follistatin is a naturally occurring binding protein that inhibits members of the TGF-β (transforming growth factor-beta) family, primarily myostatin and activin A. Myostatin acts as a strong negative regulator of muscle growth, limiting muscle cell differentiation and hypertrophy.

By binding to and neutralizing these proteins, follistatin may remove biological constraints on muscle development, allowing increased muscle fiber growth and protein synthesis. It is also involved in reproductive signaling and tissue regulation. Preclinical research has demonstrated dramatic muscle growth effects in animal models, though human data remains limited.

  • Potential Benefits & Side Effects

Observations based on preclinical and early-stage research.

Potential Benefits:

  • May significantly increase lean muscle mass
  • May enhance strength and physical performance
  • May support faster muscle recovery and growth response
  • Strong myostatin inhibition pathway activity in preclinical models

Possible Side Effects:

  • Limited human safety data available; investigational compound
  • Potential hormonal or growth signaling imbalance concerns in theory
  • Injection-site irritation
  • Long-term effects in humans have not been established